Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
This grant funds institutional training programs aimed at advancing translational research on Alzheimer's Disease and related dementias.
About this program
The Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) grant is designed to support the development of training programs that will enhance the skills and knowledge of researchers in the field of Alzheimer's and related dementias. This initiative aims to foster a new generation of scientists who are equipped to conduct impactful research that translates into effective treatments and interventions for these conditions. The program is intended for institutions that are committed to training researchers and advancing the understanding of Alzheimer's disease and ADRD. Eligible institutions will be expected to provide comprehensive training that includes mentorship, research opportunities, and educational resources. The goal is to create a robust pipeline of skilled researchers who can contribute to the field and ultimately improve outcomes for individuals affected by Alzheimer's disease and related dementias. This grant is particularly focused on enhancing translational research, which bridges the gap between laboratory discoveries and clinical applications.
Eligibility
Eligible entities include academic institutions and research organizations that can provide training programs in Alzheimer's disease and related dementias.